Lee's Pharmaceutical Holdings Limited (0950.HK)
Develops and sells prescription drugs treating blood clots, cancer, infections, and other diseases across China and Asia.
1.08+0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-37.6%
The outlook
Lee's Pharmaceutical trades at 1.08, sitting well below both its 50- and 200-day moving averages and near the lower end of its 52-week range. The stock carries a low trailing P/E of 6.8, though analyst coverage appears thin. Current market positioning reflects a weak technical setup with limited upside cushion from recent lows.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
$635.9M
52-wk high
2.70
52-wk low
0.99
50-day avg
1.08
200-day avg
1.40
Trailing P/E
6.8